|
Originally published In Press as doi:10.1074/jbc.M206786200 on July 26, 2002
J. Biol. Chem., Vol. 277, Issue 41, 38557-38564, October 11, 2002
The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming
Growth Factor- Signaling by Blocking Binding of the Smad Complex to
Its Target Sequence*
Dug Keun
Lee ,
Byung-Chul
Kim ,
Isaac Yi
Kim ,
Eun-ah
Cho ,
Daniel J.
Satterwhite§¶, and
Seong-Jin
Kim
From the Laboratory of Cell Regulation and
Carcinogenesis, National Institutes of Health, Bethesda, Maryland 20892 and the § Division of Neonatology, University of Utah, Salt
Lake City, Utah 84132
The human papillomavirus (HPV) oncoprotein E7 is
implicated in the etiology of cervical cancer associated with infection
by HPV. HPV-positive cells develop resistance to TGF- growth
inhibitory activity through the inhibition of hypophosphorylation of
pRb by papillomavirus type 16 E7 oncoprotein. In this study, we
examined whether E7, in addition to its well known effects on pRb,
might directly target the Smad proteins that mediate TGF- signaling. Here, we show that E7 significantly blocks both Smad transcriptional activity and the ability of TGF- to inhibit DNA synthesis. We found
that E7 interacts constitutively with Smad2, Smad3, and Smad4. Confocal
microscopic studies confirm that E7 and Smads co-localize in
vivo. Using a canonical Smad DNA binding sequence, we found that
E7 blocks Smad3 binding to its target sequence on DNA. These results
suggest that suppression of Smad-mediated signaling by E7 may
contribute to HPV-associated carcinogenesis.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Funded by the Huntsman Cancer Institute.
To whom correspondence should be addressed. Tel.:
301-496-8350; Fax: 301-496-8395; E-mail: kims@mail.nih.gov.
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H.-M. Lin, J.-H. Lee, H. Yadav, A. K. Kamaraju, E. Liu, D. Zhigang, A. Vieira, S.-J. Kim, H. Collins, F. Matschinsky, et al.
Transforming Growth Factor-{beta}/Smad3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet {beta}-Cell Function
J. Biol. Chem.,
May 1, 2009;
284(18):
12246 - 12257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman
KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor
Blood,
May 1, 2008;
111(9):
4731 - 4740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-A. Mendoza, Y. Jacob, P. Cassonnet, and M. Favre
Human Papillomavirus Type 5 E6 Oncoprotein Represses the Transforming Growth Factor {beta} Signaling Pathway by Binding to SMAD3
J. Virol.,
December 15, 2006;
80(24):
12420 - 12424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Choi and S. B. Hwang
Modulation of the Transforming Growth Factor-beta Signal Transduction Pathway by Hepatitis C Virus Nonstructural 5A Protein
J. Biol. Chem.,
March 17, 2006;
281(11):
7468 - 7478.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Pett, M. T. Herdman, R. D. Palmer, G. S. H. Yeo, M. K. Shivji, M. A. Stanley, and N. Coleman
Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response
PNAS,
March 7, 2006;
103(10):
3822 - 3827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Baez, A. Cantor, S. Fonseca, M. Marcos-Martinez, L. A. Mathews, C. A. Muro-Cacho, and T. Munoz-Antonia
Differences in Smad4 Expression in Human Papillomavirus Type 16-Positive and Human Papillomavirus Type 16-Negative Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res.,
May 1, 2005;
11(9):
3191 - 3197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Seo, J. Park, and J. Choe
Kaposi's Sarcoma-Associated Herpesvirus Viral IFN Regulatory Factor 1 Inhibits Transforming Growth Factor-{beta} Signaling
Cancer Res.,
March 1, 2005;
65(5):
1738 - 1747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Lee, J. K. Lee, S. Miyake, and S.-J. Kim
A Novel E1A-like Inhibitor of Differentiation (EID) Family Member, EID-2, Suppresses Transforming Growth Factor (TGF)-{beta} Signaling by Blocking TGF-{beta}-induced Formation of Smad3-Smad4 Complexes
J. Biol. Chem.,
January 23, 2004;
279(4):
2666 - 2672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Tian, S. DaCosta Byfield, W. T. Parks, S. Yoo, A. Felici, B. Tang, E. Piek, L. M. Wakefield, and A. B. Roberts
Reduction in Smad2/3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines
Cancer Res.,
December 1, 2003;
63(23):
8284 - 8292.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|